Translating autologous heart valve tissue engineering from bench to bed

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Tissue engineering offers a potential solution to limitations of current prosthetic aortic heart valves.
• Engineered heart valves possess advantages of living autologous structures, including biocompatibility and regenerative capacity.
• In vitro studies demonstrate promising structural and functional properties of tissue-engineered heart valves.

Purpose of the Study:

• To review methods for evaluating tissue-engineered heart valve functionality during the transition from in vitro to in vivo studies.
• To establish criteria for assessing the suitability of autologous heart valves for clinical application.
• To identify essential assessment criteria for the clinical applicability of tissue-engineered aortic valves.

Main Methods:

• Discussion of existing and potential techniques for evaluating tissue-engineered heart valve function.
• Focus on noninvasive assessment methods for in vivo preclinical studies.
• Analysis of criteria required for clinical translation and aortic valve replacement.

Main Results:

• In vitro studies indicate tissue-engineered heart valves possess adequate structural and functional properties.
• Preclinical animal studies are necessary to establish evaluation criteria before long-term in vivo follow-up.
• Development of noninvasive techniques is a critical next step for translational research.

Conclusions:

• Tissue-engineered heart valves represent a promising advancement in cardiovascular repair.
• Establishing robust, noninvasive in vivo evaluation methods is imperative for clinical translation.
• Defined assessment criteria are essential for the successful application of tissue-engineered aortic valves in patients.